Skip to main content
Clinical Trials/IRCT20211212053361N1
IRCT20211212053361N1
Recruiting
Phase 2

Safety and efficacy of Injection of Human Placenta Mesenchymal Stem Cells Derived Exosomes for treatment of complex Anal Fistula

Tehran University of Medical Sciences0 sites15 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Tehran University of Medical Sciences
Enrollment
15
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age between 18\-70 years old
  • Complex perianal fistula
  • Informed consent

Exclusion Criteria

  • Active inflammatory bowel disease
  • Synchronous perianalabcess
  • Alcohol, narcotic and stimulant consumption
  • Having active hepatitis B,C, HIV or TB
  • Pregnancy and lactation
  • Uncontrolled diabetes mellitus
  • Evidence of surgical contraindication
  • Psychological disorders and noncooperative pateint

Outcomes

Primary Outcomes

Not specified

Similar Trials